{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:15:44Z","timestamp":1773465344966,"version":"3.50.1"},"reference-count":32,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2021,9,30]]},"DOI":"10.7883\/yoken.jjid.2020.542","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T22:09:36Z","timestamp":1614290976000},"page":"473-476","source":"Crossref","is-referenced-by-count":2,"title":["Persistence of Anti-Rubella Immunoglobulin G Antibody Titers in Young Adults Involved in a Short-Term Periodic Immunization in Japan"],"prefix":"10.7883","volume":"74","author":[{"given":"Hiraku","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Health Science, Juntendo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Section of Health Management, Juntendo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Asano","sequence":"additional","affiliation":[{"name":"Section of Health Management, Juntendo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Tsumita","sequence":"additional","affiliation":[{"name":"Department of Health Science, Juntendo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Sports Science, Faculty of Health and Sports Science, Juntendo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuto","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Juntendo Tokyo Koto Geriatric Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. Cutts FT, Robertson SE, Diaz-Ortega JL, et al. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ. 1997;75:55-68."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fuccillo DA, Steele RW, Hensen SA, et al. Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun. 1974;9:81-4.","DOI":"10.1128\/iai.9.1.81-84.1974"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shishido A, Ohtawara M. Development of attenuated rubella virus vaccines in Japan. Jpn J Med Sci Biol. 1976;29:227-53.","DOI":"10.7883\/yoken1952.29.227"},{"key":"4","unstructured":"4. Vaccination Office, Health Service Division, Health Survice Bureau. Policy history of routine vaccination against rubella. Infect Agents Surveillance Rep. 2019;40:130-1. Japanese."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ueda K, Miyazaki C, Hidaka Y, et al. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet. 1995:346:701-2.","DOI":"10.1016\/S0140-6736(95)92311-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakayama T. Vaccine chronicle in Japan. J Infect Chemother. 2013:19:787-98.","DOI":"10.1007\/s10156-013-0641-6"},{"key":"7","unstructured":"7. Terada K. Rubella and congenital rubella syndrome in Japan: epidemiological problems. Jpn J Infect Dis. 2003:56:81-7."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ueda K. Epidemiology of rubella and congenital rubella syndrome in Japan before 1989. Vaccine. 2016;34:1971-4.","DOI":"10.1016\/j.vaccine.2015.10.010"},{"key":"9","unstructured":"9. Taya K. Revision of measles and rubella reporting to notification of all cases and second routine immunization with MR vaccine to the youth. Infect Agents Surveillance Rep. 2008; 29: 189-90. Japanese."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Katow S. Surveillance of congenital rubella syndrome in Japan, 1978\u20132002: effect of revision of the immunization law. Vaccine. 2004;22:4084-91.","DOI":"10.1016\/j.vaccine.2004.03.055"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tanaka Y, Ueda Y, Yoshino K, et al. History repeats itself in Japan: failure to learn from rubella epidemic leads to failure to provide the HPV vaccine. Hum Vaccin Immunother. 2017;13:1859-60.","DOI":"10.1080\/21645515.2017.1327929"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saitoh A, Okabe N. Progress and challenges for the Japanese immunization program: beyond the "vaccine gap." Vaccine. 2018;36:4582-8.","DOI":"10.1016\/j.vaccine.2018.01.092"},{"key":"13","unstructured":"13. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Measles and rubella\/congenital rubella syndrome in Japan, as of March 2016. Infect Agents Surveillance Rep. 2016;37:59-61. Japanese."},{"key":"14","unstructured":"14. Centers for Disease Control and Prevention (CDC). Nationwide rubella epidemic--Japan, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:457-62."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ujiie M. Rubella resurgence in Japan 2018\u20132019. J Travel Med. 2019;26:taz047.","DOI":"10.1093\/jtm\/taz047"},{"key":"16","unstructured":"16. Komori T. Towards rubella elimination by FY2020. Infect Agents Surveillance Rep. 2016;37:78-80. Japanese."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fujinaga T, Motegi Y, Tamura H, et al. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr Infect Dis J. 1991;10:204-9.","DOI":"10.1097\/00006454-199103000-00007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kimura M, Kuno-Sakai H, Yamazaki S, et al. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn. 1996;38:205-11.","DOI":"10.1111\/j.1442-200X.1996.tb03471.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ueda K. Development of the rubella vaccine and vaccination strategy in Japan. Vaccine. 2009;27:3232-3.","DOI":"10.1016\/j.vaccine.2009.02.076"},{"key":"20","unstructured":"20. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Rubella and Congenital Rubella Syndrome in Japan, as of March 2013. Infect Agents Surveillance Rep.2013;34: 87-9. Japanese."},{"key":"21","unstructured":"21. CDC. Nationwide rubella epidemic\u2013Japan, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:457-62."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sugishita Y, Shimatani N, Katow S, et al. Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012-2013 epidemics in Tokyo, Japan. Jpn J Infect Dis. 2015;68:159-65.","DOI":"10.7883\/yoken.JJID.2014.195"},{"key":"23","unstructured":"23. Sato H, Taya K, Mori Y. Interim report on rubella seroepidemiology and rubella vaccine coverage in the FY2012 (as of March 5, 2013) \u2212NESVPDI. Infect Agents Surveillance Rep. 2013; 34: 105-7. Japanese."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okafuji T, Okafuji T, Nakayama T. Persistence of immunity acquired after a single dose of rubella vaccine in Japan. Jpn J Infect Dis. 2016;69:221-3.","DOI":"10.7883\/yoken.JJID.2015.162"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Shoho Y, Kimura T, Yanagawa Y, et al. Vaccination status and antibody titers against rubella and measles among Japanese female college students majoring in childcare between 2015 and 2018. Tohoku J Exp Med. 2018;246:73-9.","DOI":"10.1620\/tjem.246.73"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Christenson B, B\u00f6ttiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine. 1994;12:41-5.","DOI":"10.1016\/0264-410X(94)90009-4"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Johnson CE, Kumar ML, Whitwell JK, et al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J. 1996;15:687-92.","DOI":"10.1097\/00006454-199608000-00010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. LeBaron CW, Forghani B, Matter L, et al. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis. 2009;200:888-99.","DOI":"10.1086\/605410"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tischer A, Gerike E. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Vaccine. 2000;18:1382-92.","DOI":"10.1016\/S0264-410X(99)00397-7"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Bianchi FP, De Nitto S, Stefanizzi P, et al. Immunity to rubella: an Italian retrospective cohort study. BMC Public Health. 2019;19:1490.","DOI":"10.1186\/s12889-019-7829-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Carryn S, Feyssaguet M, Povey M, et al. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: a 10-year follow-up. Vaccine. 2019;37:5323-31.","DOI":"10.1016\/j.vaccine.2019.07.049"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sasaki H, Fukunaga T, Asano A, et al. A survey of vaccine-induced measles IgG antibody titer to verify temporal changes in response to measles vaccination in young adults. Vaccines (Basel). 2019;7:118.","DOI":"10.3390\/vaccines7030118"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/5\/74_JJID.2020.542\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T03:51:48Z","timestamp":1632541908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/5\/74_JJID.2020.542\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2020.542","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"article-number":"JJID.2020.542"}}